Changes to the nation’s healthcare system as proposed in the pending Graham-Cassidy health legislation could leave millions of cancer patients and survivors without access to adequate, affordable health insurance coverage, according to Dick Woodruff, senior vice president of federal advocacy for ACS CAN.
This week the Senate HELP Committee is hearing from bipartisan health care experts in its ongoing effort to strengthen the individual insurance market and ensure that meaningful, affordable health care coverage is available for millions of Americans, including cancer patients, survivors and their families.
The Congressional Budget Office (CBO) today released its assessment of what would happen to health insurance premiums should the administration stop paying cost-sharing reductions (CSRs).
The CBO projects the average monthly premiums would increase 20 percent next year and 25 percent by 2020.
The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.
The U.S. Food and Drug Administration announced today a new, comprehensive approach to confront nicotine addiction in the U.S. through the agency’s authority over tobacco products.
The U.S. Senate is reported to be considering a “skinny” health care repeal bill that according to earlier Congressional Budget Office estimates of similar repeal could cause 15 million Americans to lose their insurance coverage over the next ten years
A new report shows that while opportunities for coverage have improved, cancer patients still struggle with significant financial challenges in affording their treatment despite substantial reductions in out-of-pocket costs and patient protections under current law.
Six leading public health organizations today asked federal courts to allow them to intervene in two lawsuits brought by the electronic cigarette and cigar industries against the Food and Drug Administration’s 2016 rule establishing public health oversight of e-cigarettes, cigars and other previously unregulated tobacco products
The House Labor, Health and Human Services and Education Committee marked up its FY 2018 spending bill today including a $1.1 billion funding increase for the National Institutes of Health (NIH) and a $82 million funding boost for the National Cancer Institute (NCI).
Unlike the House version of this bill, senators did not exempt from FDA oversight many cigars, including some cheap and flavored cigars often popular with youth. The Committee’s action preserves FDA authority to regulate all tobacco products as granted by Congress